APOL1-Mediated Kidney Disease

Timothy Hopper; Opeyemi A Olabisi

doi:10.1001/jama.2024.2667

APOL1-Mediated Kidney Disease

JAMA. 2024 Apr 25. doi: 10.1001/jama.2024.2667. Online ahead of print.

Authors

Timothy Hopper¹, Opeyemi A Olabisi^{1

2}

Affiliations

¹ Division of Nephrology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina.
² Duke Molecular Physiology Institute, Duke University School of Medicine, Durham, North Carolina.

PMID: 38662391
DOI: 10.1001/jama.2024.2667

No abstract available

Plain language summary

This JAMA Insights reviews the origin of APOL1 high-risk genetic variants, defines APOL1-mediated kidney disease, and discusses recommendations for screening and management.